Network News

Please remember to cite the CFAR. Citing the CFAR grant number (AI050409) on all publications and presentations that benefited from any level of Emory CFAR consultation, services, materials, mentorship, or funding is crucial in ensuring our continued support from NIH.

Nadine Rouphael		Colleen Kelley		Carlos del Rio		Valeria Cantos		Aneesh Mehta

... to the Emory Team who led the enrollment of more patients (n=103) into the Adaptive COVID-19 Treatment Trial (ACTT) than any of the other 67 sites around the world. ACTT is a NIAID-funded clinical trial of the COVID-19 drug Remdesivir (NCT04280705).

According to preliminary data from ACTT, hospitalized people with advanced COVID-19 and lung involvement who received Remdesivir recovered faster than similar people who received placebo, making it the new standard of care for patients hospitalized with SARS-CoV-2.

Read More About It:
• A Glimmer of Hope for Coronavirus Patients
• Emory Helps Lead Research on Drug to Treat COVID-19 Patients

	Speaking of HIV & PrEP... In 2019 Natalie Crawford spun a CFAR Opportunity Award into an NIH R34 that is Advancing PrEP Access in Pharmacies to Improve PrEP Uptake in Disadvantaged Areas. • Read More About It

Patrick Sullivan		Colleen Kelley

Back in 2014 Patrick Sullivan and Eli Rosenberg received R01 funding (R01DA038196) to develop a prospective cohort study of 300 HIV-negative young black MSM in Atlanta. A lot of interesting results came out of that study
(check it out here).

During that study they offered PrEP as part of a comprehensive package of prevention interventions.

Good News: Over 40% of cohort participants initiated PrEP

Bad News: Almost 40% of the men who initiated PrEP discontinued it before the study was over.

Worse News: Even with 44% PrEP uptake in the cohort, HIV incidence remained high at 6.2%/year. New STI diagnoses remained high as well.

Great News: Patrick Sullivan and Colleen Kelley have just received new R01 funding to look at Parrying the Pitfalls of PrEP: Preventing Premature PrEP Discontinuation and STIs Among Young Black MSM (R01MH122341).

This new study will continue the cohort approach but will also add three new interventions:
(1) An innovative "early warning" system to identify YBMSM on PrEP who are at risk for discontinuing PrEP, and then provide a motivational interviewing-based peer intervention.

(2) On-demand PrEP offered to men who decline daily PrEP or who plan to stop daily PrEP because they are unwilling to take a daily pill or perceive their risks to be infrequent.

(3) STI PEP with doxycycline offered to all men, regardless of PrEP use, to avert new STIs.

• Read More About It

Larry Kramer, Playwright and AIDS Activist

"He sought to shock the country into dealing with AIDS as a public-health emergency and foresaw that it could kill millions regardless of sexual orientation."

• New York Times Obituary

Last Call for Abstracts: 8/4/20 Pediatric Research and Career Development Symposium
Deadline: June 1, 2020 (1:00pm)
Who can submit an abstract: Child health researchers who are trainees, postdocs, fellows and junior faculty with a rank of no higher than assistant professor are invited to submit abstracts as the lead author. Select abstracts will be invited to do oral presentations.
• Start an Abstract
• More Information about the Symposium

From Sharon Milgram (NIH OHITE):
Have you been on the receiving end of unkind language, bullying and microaggressions?

Or have you witnessed someone in your group treated with disrespect?

Have you ever found yourself unsure of what to say, either in the moment or after the fact?

Perhaps you are a mentor and want to learn how to support your trainees when they report incivility to you?

Or you plan to become a physician, a teacher, the head of a research group, or play another important role in healthcare or research?

Regardless of where you are now and where you want to be in the future, we all need practice and discussion to develop the skills necessary for making our work environments welcoming and inclusive for all.

Please join us for a one-hour special small group discussion to explore the concept of speaking up in the face of disrespect of yourself and others using a case study approach --- From bystander to upstander: dealing with incivility and microaggressions at school/work and beyond.

REGISTER FOR ONE OF THE MAY 28 SMALL GROUP DISCUSSIONS
• 9:00 - 10:00: Trainees & Staff
• 11:00 - 12:00: Trainees & Staff
• 1:00 - 2:00: Trainees & Staff
• 1:00 - 2:00: Trainees Only
• 3:00 - 4:00: Trainees Only

REGISTER FOR ONE OF THE MAY 29 SMALL GROUP DISCUSSIONS
• 9:00 - 10:00: Trainees & Staff
• 11:00 - 12:00: Trainees & Staff
• 1:00 - 2:00: Trainees & Staff
• 1:00 - 2:00: Trainees Only
• 3:00 - 4:00: Trainees Only

You will get the most out of the small group discussion if you first watch the NIH webinar on bystander training – but if you cannot, join us anyway and watch the webinar later.

We hope you join us as we explore how to better support ourselves and each other in the face of disrespect, incivility and microaggressions, especially during these trying times.

Best,
Sharon

Dr. Sharon L. Milgram
Director, NIH Office of Intermural Training & Education (OHITE)
Sharon.milgram@nih.gov

www.training.nih.gov
On Twitter @SHARONMILGRAM // @NIH_OITE

It's That Time of YEAR!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

We… NEED… YOU!!!!

We are 82 days away from the premiere GA youth advocacy conference!

Join SisterLove, Inc. for our annual Youth Conference, HLYASS!
August 17-23, 2020!

This year, HLYASS will be VIRTUAL!

Registration is now open!

Youth ages 16-25 can register for FREE.

• Register for HLYASS 2020

On May 6, IAPAC hosted an Adherence 2020 virtual pre-conference on: "Continuity of HIV Care in the Presence of COVID-19." It featured clinical and community experts who spoke to the importance of uninterrupted access to HIV prevention, care, treatment, and psychosocial support services.

• Watch the recordings

TB scientist: "I spend my days in the lab — or at least I used to — wearing a T-shirt and mask ... or, as we call it these days, "Business Casual" ... trying to find the best way to kill TB germs. I dip them in acid, I chop them up into little pieces, I set them on fire, and basically do anything else I can think of to them. If God turns out to be a microbe, I'm screwed."

Welcome to Science Riot, where MDs and PhDs turn their day jobs into stand up comedy.

MARK YOUR CALENDAR NOW: Science Riot will be live streaming from ATLANTA on Saturday, June 13 (Trivia: 8:30pm, Main Event: 9:00-10:00pm)!!

Click here for tickets today and share Science Riot on Facebook. Your ticket-purchase (no set price, donate any amount you can) will generate a confirmation email that will contain the secret link to the streaming event on June 13.

This event will be held in partnership with Science for Georgia, a non-profit organization that provides roadmaps for scientists to engage with communities.

The Network News is a periodic email, detailing HIV/AIDS related events, funding opportunities, and achievements of CFAR members. If you have items that you wish to have included, please send them to us at cfar@emory.edu by Friday of each week. Please put "The Network News" in the subject line.

The Network News is distributed to CFAR members and fans by email every Wednesday. Except when it isn't.

Editor, Kimbi Sessions Hagen, EdD